Advanced search
Publication Cover
Expert Review of Anticancer Therapy Volume 11, 2011 - Issue 4
Submit an article Journal homepage
71
Views
7
CrossRef citations to date
0
Altmetric
Review

Combining biological agents and chemotherapy in the treatment of cholangiocarcinoma

Lars Henrik Jensen Danish Colorectal Cancer Group South, Vejle Hospital, Kabbeltoft 25, DK-7100 Vejle, Denmark.; Danish Colorectal Cancer Group South, Vejle Hospital, Kabbeltoft 25, DK-7100 Vejle, Denmark.
&
Anders Jakobsen Danish Colorectal Cancer Group South, Vejle Hospital, Kabbeltoft 25, DK-7100 Vejle, Denmark.;[email protected]
Pages 589-600 | Published online: 10 Jan 2014

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Lars Henrik Jensen. (2016) Clinical aspects and perspectives of erlotinib in the treatment of patients with biliary tract cancer. Expert Opinion on Investigational Drugs 25:3, pages 359-365.
Read now

Articles from other publishers (6)

Nadia Emad Lotfi Amin, Torben Frøstrup Hansen, Eva Fernebro, John Ploen, Jakob Eberhard, Jan Lindebjerg & Lars Henrik Jensen. (2021) Randomized Phase II trial of combination chemotherapy with panitumumab or bevacizumab for patients with inoperable biliary tract cancer without KRAS exon 2 mutations . International Journal of Cancer 149:1, pages 119-126.
Crossref
Jian-Peng Cai, Wei Chen, Xun Hou, Li-Jian Liang, Xiao-Yi Hao & Xiao-Yu Yin. (2013) Simvastatin enhances the chemotherapeutic efficacy of S-1 against bile duct cancer. Anti-Cancer Drugs 24:10, pages 1020-1029.
Crossref
Elisa Herraez, Elisa Lozano, Rocio I.R. Macias, Javier Vaquero, Luis Bujanda, Jesus M. Banales, Jose J.G. Marin & Oscar Briz. (2013) Expression of SLC22A1 variants may affect the response of hepatocellular carcinoma and cholangiocarcinoma to sorafenib . Hepatology 58:3, pages 1065-1073.
Crossref
L.H. Jensen, J. Lindebjerg, J. Ploen, T.F. Hansen & A. Jakobsen. (2012) Phase II marker-driven trial of panitumumab and chemotherapy in KRAS wild-type biliary tract cancer. Annals of Oncology 23:9, pages 2341-2346.
Crossref
E. Boucher. (2012) Traitement médical des cholangiocarcinomes: de l’adjuvant au métastatique, du nouveau ?Medical treatment of biliary tract cancer: from peri-operative to palliative care, what’s on?. Oncologie 14:3, pages 150-157.
Crossref
Lars Henrik Jensen. (2012) Biliary-tract cancer: improving therapy by adding molecularly targeted agents. The Lancet Oncology 13:2, pages 118-119.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.